MondelezColgate-Palmolive

Mondelez vs Colgate-Palmolive

Global snacks and confectionery leader with strong brands vs Global oral care and household products leader. Which is the better buy for your portfolio in June 2026? Plain-English answer below.

Mondelez International sells snacks and confections across dozens of countries, using its global distribution network and beloved brands like Oreo and Cadbury to push volume while raising prices faste...

Why It’s Moving

Mondelez

MDLZ is holding near a steady analyst backdrop as recent target hikes signal confidence in brand strength and pricing power.

  • DA Davidson and Piper Sandler both raised their price targets to $64 while keeping Neutral ratings, signaling that recent results were solid enough to support modestly better expectations.
  • Broader Street sentiment remains constructive, with consensus ratings clustering around Buy or Moderate Buy, which shows analysts still see Mondelez as a defensive consumer name with earnings resilience.
  • The recent target revisions appear tied to brand investments and earnings outlooks, implying the market is weighing long-term pricing power against slower volume growth and cost pressure.
Sentiment:
⚖️Neutral
Colgate-Palmolive

Colgate-Palmolive is sliding on valuation worries as analysts flag limited upside and a possible 8% downside.

  • Recent analyst commentary has been mixed to mildly positive overall, but the spread between the highest and lowest targets shows that expectations are no longer uniformly upbeat.
  • The bearish case centers on valuation: even with steady demand for household staples, analysts see less room for the stock to rerate higher after its recent move.
  • With no major company-specific catalyst in the last week, trading appears tied more to broader consumer staples sentiment and investor preference for defensive names than to fresh operating news.
Sentiment:
⚖️Neutral

Investment Analysis

Pros

  • Mondelez has strong pricing power and strategic cost controls, including efficient cocoa sourcing adjustments to manage tariff impacts.
  • It is positioned for sustained long-term growth by expanding in emerging markets and shifting towards healthier product options.
  • The company has scale advantages that support profitability even amid commodity cost volatility and inflation pressures.

Considerations

  • Recent Q3 2025 results showed a revenue shortfall and margin pressure from historically high cocoa costs, causing a negative market reaction.
  • Its stock price has declined significantly over the past year, reflecting concerns about ongoing cost inflation and macroeconomic risks.
  • Sensitivity to commodity and tariff fluctuations poses risks to supply chain stability and profit margins, creating uncertainty.

Pros

  • Colgate-Palmolive maintains a broad, well-established global brand presence with a diversified product portfolio in oral care and personal products.
  • The company benefits from relatively stable demand and less commodity cost volatility compared to food-focused peers.
  • It has demonstrated consistent profitability with efficient cost management and resilient cash flow generation.

Considerations

  • Colgate-Palmolive has experienced stock underperformance compared to peers, impacted by modest organic growth challenges.
  • Growth prospects may be limited by mature market exposure and competitive intensity in key categories like oral care.
  • The company faces execution risks related to innovation pace and evolving consumer preferences in a crowded personal care market.

Mondelez (MDLZ) Next Earnings Date

The next earnings date for MDLZ is typically expected around July 28, 2026, based on its recent reporting pattern, though the company has not formally confirmed it yet. This report would cover Q2 2026 results. If the schedule shifts, the announcement could fall within the last week of July.

Colgate-Palmolive (CL) Next Earnings Date

Colgate-Palmolive’s next earnings release is expected on July 31, 2026, based on the company’s usual late-July reporting pattern. The upcoming report should cover Q2 2026. If management confirms the date formally, it will likely be announced closer to the release window.

Buy MDLZ or CL in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions

MDLZ
MDLZ$63.60
vs
CL
CL$90.00
Buy MDLZ